TY - JOUR
T1 - A score predicting survival after liver retransplantation for hepatitis C virus cirrhosis
AU - Andres, Axel
AU - Gerstel, Eric
AU - Combescure, Christophe
AU - Asthana, Sonal
AU - Merani, Shaheed
AU - Majno, Pietro
AU - Berney, Thierry
AU - Morel, Philippe
AU - Kneteman, Norman
AU - Mentha, Gilles
AU - Toso, Christian
PY - 2012/4/15
Y1 - 2012/4/15
N2 - Background. Approximately one fourth of patients transplanted for hepatitis C virus (HCV)-induced liver failure progress to cirrhosis within 5 years, potentially requiring retransplantation. Although the relisting decision can be difficult in these patients, a score could help in selection of candidates with the best potential outcomes. Methods. A total of 1422 HCV-positive patients having undergone a retransplantation were included in this registry-based study. A multivariate Cox regression was performed, and an Akaike procedure was applied to design a score predicting survival after retransplantation and to allow an internal validation. Retained variables were donor age (DnAge), serum creatinine (Creat), International Normalized Ratio (INR), and serum albumin (Alb) at the second transplantation, recipient age (RecAge) at the first transplantation, and the interval between both transplantations (Int). Results. The score was designed as 0.23×DnAge+4.86×log Creat-2.45×log Int+2.69×INR+0.10×RecAge-3.27× Alb+40. The receiver operating characteristic area under curve was 0.643 at 3 years, and survivals were 71%, 56%, and 37% for scores <30, 30 to 40, and >40, respectively (log rank <0.0001). Conclusions. Overall, the proposed score is specifically designed for HCV-positive patients, accurately predicts survival after a liver retransplantation, and is helpful in the selection of candidates with the best potential outcomes.
AB - Background. Approximately one fourth of patients transplanted for hepatitis C virus (HCV)-induced liver failure progress to cirrhosis within 5 years, potentially requiring retransplantation. Although the relisting decision can be difficult in these patients, a score could help in selection of candidates with the best potential outcomes. Methods. A total of 1422 HCV-positive patients having undergone a retransplantation were included in this registry-based study. A multivariate Cox regression was performed, and an Akaike procedure was applied to design a score predicting survival after retransplantation and to allow an internal validation. Retained variables were donor age (DnAge), serum creatinine (Creat), International Normalized Ratio (INR), and serum albumin (Alb) at the second transplantation, recipient age (RecAge) at the first transplantation, and the interval between both transplantations (Int). Results. The score was designed as 0.23×DnAge+4.86×log Creat-2.45×log Int+2.69×INR+0.10×RecAge-3.27× Alb+40. The receiver operating characteristic area under curve was 0.643 at 3 years, and survivals were 71%, 56%, and 37% for scores <30, 30 to 40, and >40, respectively (log rank <0.0001). Conclusions. Overall, the proposed score is specifically designed for HCV-positive patients, accurately predicts survival after a liver retransplantation, and is helpful in the selection of candidates with the best potential outcomes.
KW - Hepatitis C
KW - Liver transplantation
KW - Retransplantation
KW - Score
KW - Survival
UR - http://www.scopus.com/inward/record.url?scp=84859268298&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84859268298&partnerID=8YFLogxK
U2 - 10.1097/TP.0b013e318246f8b3
DO - 10.1097/TP.0b013e318246f8b3
M3 - Article
C2 - 22267157
AN - SCOPUS:84859268298
SN - 0041-1337
VL - 93
SP - 717
EP - 722
JO - Transplantation
JF - Transplantation
IS - 7
ER -